...
首页> 外文期刊>Journal of Forensic Radiology and Imaging >Perinatal death: Is there a place for post-mortem angio-CT?
【24h】

Perinatal death: Is there a place for post-mortem angio-CT?

机译:围产期死亡:在验尸anio-ct的地方是否存在?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To study the feasibility of perinatal post-mortem computed tomography angiography (PMCTA) and to evaluate the informations provided. Material and methods: From January to March 2014, we included all fetuses referred to our fetopathology unit for intra-uterine fetal death or termination (IUFD) or pregnancy (TOP). We noted sex, gestational age in weeks[U+05F3] gestation (WG) at referral, and reason for TOP. All bodies were scanned with the same CT device using the same protocol, before and after contrast injection. We analyzed the success rate of the injection, the quality of vascular filling and the informations provided compared to prenatal data and confirmed by standard autopsy for all patients. Results: We prospectively included 17 consecutive attempts of PMCTA in fetuses aged 16-37 WG (mean 28), 9 were male and 8 were female, originating from intra-uterine fetal death (n=4, 23.5%) or termination of pregnancy (n=13, 76.5%). Injection failed in 4 cases (23%). In the 13 successful others (77%), injection was quoted sub-optimal in 2 cases (15%). Overall, additional informations were provided by PMCTA in 5 cases (29%), meaning 38% of cases when injection was successful. Conclusion: Perinatal PMCTA is feasible and provides additional data compared to prenatal imaging. We strongly believe it is a very promising technique, especially in association with ultrasound, more or less dedicated brain MRI.
机译:为研究鼠后验尸血管造影血管造影(PMCTA)的可行性,并评估提供的信息。材料和方法:2014年1月至3月,我们包括所有胎病理学单位的所有胎儿,用于子宫内胎儿死亡或终止(IUFD)或怀孕(上)。我们注意到性行为,在几周[U + 05F3]妊娠(WG)的妊娠(WG),以及顶部的原因。使用相同的协议,在对比注射之前和之后,使用相同的CT器件扫描所有机构。我们分析了注射的成功率,血管填充质量和与产前数据相比提供的信息,并通过标准尸检确认所有患者。结果:我们预期包括16-37 WG(平均28),9名胎儿胎儿PMCTA的连续尝试,9是雄性,8是女性,源自子宫内胎儿死亡(n = 4,23.5%)或妊娠期终止( n = 13,76.5%)。注射失败4例(23%)。在13个成功的其他(77%)中,注射在2例(15%)中被引用次优。总体而言,PMCTA在5例(29%)中提供了其他信息,意思是注射成功的38%的病例。结论:围产期PMCTA是可行的,与产前成像相比提供额外的数据。我们坚信这是一种非常有希望的技术,特别是与超声波,或多或少的专用脑MRI相关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号